NTAGI meeting on vaccination for 5-12-year-olds inconclusive: Sources

  

India’s vaccine think-tank the National Technical Advisory Group on Immunisation (NTAGI) meeting to discuss vaccination protocol for 5-12 year old kids remained inconclusive on Wednesday, according to sources.

The NTAGI members reviewed data from vaccine makers for 5-12 year old kids, but no decision on whether to expand the program to this younger group was taken.

Last month the regulator had approved two vaccines--Serum Institute's Covovax and Biological E-made Corbevax--for use in 5-12-year-old children.

However the NTAGI decides on whether these would be used in India's Covid-19 vaccination programme.

Read Complete Article


Comments

Popular posts from this blog

Tech billionaires making friends with Big Brother

Apple acquires weather app Dark Sky, to shut down Android version in June

Finance Ministry tells state-run banks to shore up credit to MSMEs